<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Laghlam D</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Takotsubo cardiomyopathy (TTC) is a rare entity after cardiac surgery.&lt;h4>Aims&lt;/h4>To describe patients' profile who developed postoperative TTC after cardiac surgery, management, and outcomes.&lt;h4>Methods&lt;/h4>We performed a systematic literature search to extract cases of TTC after adult cardiac surgery (from 1990 to 2021). Additionally, we extracted all cases of TTC in a prospective single-center cohort database of 10,000+ patients (from 2007 to 2019). We then combined all cases in a single cohort to describe its clinical features.&lt;h4>Results&lt;/h4>From 694 screened articles, we retained 71 individual cases published in 20 distinct articles (19 cases reports and 1 case-series). We combined these to 10 cases extracted from our cohort [among 10,682 patients (0.09%)]. Overall, we included 81 cases. Patients were aged 68 ± 10 years-old and 64/81 (79%) were women. Surgery procedures included mitral valve and/or tricuspid valve surgery in 70/81, 86%. TTC was diagnosed in the first days after surgery [median 4 (1-4) days]. Incidence of cardiogenic shock, defined as requirement of vasopressor and/or inotropic support was 24/29, 83% (data available on 29/81 patients). Refractory cardiogenic appeared in 5/81, 6% who required implantation of arterio-venous extra-corporeal membrane oxygenation, and 6/81, 7%, intra-aortic balloon pump. In-hospital mortality was 5/81, 6%.&lt;h4>Conclusion&lt;/h4>This systematic review, based on case reports and case series, showed that postoperative TTC appears as a rare complication after cardiac surgery and mainly occurred after mitral and/or tricuspid valve repair procedures. In this population, TTC is associated with high rate of cardiogenic shock.</pubmed_abstract><journal>Frontiers in cardiovascular medicine</journal><pagination>1067444</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9871635</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Takotsubo cardiomyopathy after cardiac surgery: A case-series and systematic review of literature.</pubmed_title><pmcid>PMC9871635</pmcid><pubmed_authors>Touboul O</pubmed_authors><pubmed_authors>Brusset A</pubmed_authors><pubmed_authors>Dib JC</pubmed_authors><pubmed_authors>Estagnasie P</pubmed_authors><pubmed_authors>Nguyen LS</pubmed_authors><pubmed_authors>Laghlam D</pubmed_authors><pubmed_authors>Baccouche M</pubmed_authors><pubmed_authors>Squara P</pubmed_authors><pubmed_authors>Herry M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Takotsubo cardiomyopathy after cardiac surgery: A case-series and systematic review of literature.</name><description>&lt;h4>Background&lt;/h4>Takotsubo cardiomyopathy (TTC) is a rare entity after cardiac surgery.&lt;h4>Aims&lt;/h4>To describe patients' profile who developed postoperative TTC after cardiac surgery, management, and outcomes.&lt;h4>Methods&lt;/h4>We performed a systematic literature search to extract cases of TTC after adult cardiac surgery (from 1990 to 2021). Additionally, we extracted all cases of TTC in a prospective single-center cohort database of 10,000+ patients (from 2007 to 2019). We then combined all cases in a single cohort to describe its clinical features.&lt;h4>Results&lt;/h4>From 694 screened articles, we retained 71 individual cases published in 20 distinct articles (19 cases reports and 1 case-series). We combined these to 10 cases extracted from our cohort [among 10,682 patients (0.09%)]. Overall, we included 81 cases. Patients were aged 68 ± 10 years-old and 64/81 (79%) were women. Surgery procedures included mitral valve and/or tricuspid valve surgery in 70/81, 86%. TTC was diagnosed in the first days after surgery [median 4 (1-4) days]. Incidence of cardiogenic shock, defined as requirement of vasopressor and/or inotropic support was 24/29, 83% (data available on 29/81 patients). Refractory cardiogenic appeared in 5/81, 6% who required implantation of arterio-venous extra-corporeal membrane oxygenation, and 6/81, 7%, intra-aortic balloon pump. In-hospital mortality was 5/81, 6%.&lt;h4>Conclusion&lt;/h4>This systematic review, based on case reports and case series, showed that postoperative TTC appears as a rare complication after cardiac surgery and mainly occurred after mitral and/or tricuspid valve repair procedures. In this population, TTC is associated with high rate of cardiogenic shock.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-22T06:15:03.34Z</modification><creation>2025-04-05T21:39:50.503Z</creation></dates><accession>S-EPMC9871635</accession><cross_references><pubmed>36704455</pubmed><doi>10.3389/fcvm.2022.1067444</doi></cross_references></HashMap>